Manufacturing· October 5, 2026 · 24 min read
Reference vs Retention Samples: Planning Storage and Future Testing
By Ran Chen
Archive
Every article
533 articles across the biopharma commercial, regulatory, and access stack.
Pricing & Access· October 4, 2026 · 26 min read
Medicare and Patient Assistance: Program Eligibility Is Not Uniform
By Ran Chen
Manufacturing· October 3, 2026 · 23 min read
Drug Shortage Notifications: Interruption vs Permanent Discontinuation
By Ran Chen
Pricing & Access· October 2, 2026 · 28 min read
Part D Emergency Supplies in Long-Term Care: Which Policy Applies?
By Ran Chen
Policy· October 1, 2026 · 24 min read
Part B Self-Administered Drug Exclusions: Checking the Local Policy
By Ran Chen
Pricing & Access· September 30, 2026 · 23 min read
Copay Assistance Limits: What Happens When the Annual Maximum Is Reached?
By Ran Chen
Pricing & Access· September 29, 2026 · 29 min read
A New Insurance Plan: Does the Old Prior Authorization Transfer?
By Ran Chen
Manufacturing· September 28, 2026 · 32 min read
Nitrosamine Risk Reviews: What to Request From an API Supplier
By Ran Chen
Specialty· September 27, 2026 · 31 min read
Home Infusion Coverage: Separating the Drug, Supplies, and Nursing
By Ran Chen
Biosimilars· September 26, 2026 · 20 min read
Unbranded Biologics vs Biosimilars: Reading the Product Identity
By Ran Chen